Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Law, A. J. Articles by Harrison, P. J. Search for Related Content PubMed Citation Articles by Law, A. J. Articles by Harrison, P. J. Neurotransmitters Bipolar Disorder Depression Schizophrenia Spectrum Disorders Molecular Biology Other Neuroanatomy Related Article

Reduced Spinophilin But Not Microtubule-Associated Protein 2 Expression in the Hippocampal Formation in Schizophrenia and Mood Disorders: Molecular Evidence for a Pathology of Dendritic Spines

OBJECTIVE: Aberrant synaptic connectivity may underlie the involvement of the hippocampus in schizophrenia. There is reasonable neuropathological evidence for a presynaptic pathology but few studies of the postsynaptic component. This study tested the hypothesis that hippocampal dendritic pathology is also present in schizophrenia. METHOD: Using in situ hybridization in sections of hippocampal formation from 10 patients with schizophrenia, 10 patients with mood disorders (three with bipolar disorder and seven with major depression), and 10 healthy comparison subjects, the authors examined the expression of two important dendritic genes: spinophilin, which serves as a marker of dendritic spines, and microtubule-associated protein 2 (MAP2), an overall dendritic marker. RESULTS: The patients with schizophrenia had lower levels of spinophilin mRNA in CA4 (hilus), CA3, the subiculum, and the entorhinal cortex than did the normal comparison subjects. The mood disorder group showed similar differences from the comparison group. MAP2 and cyclophilin mRNA did not differ between the groups in any subfield. CONCLUSIONS: Decreased spinophilin but unchanged MAP2 expression provides molecular evidence for a hippocampal dendritic pathology in schizophrenia that preferentially affects the spines. As spines are the target of most glutamatergic synapses, the data extend the evidence that excitatory synapses are particularly affected. Similar dendritic spine pathology may also occur in mood disorders.

Related Article:

In This Issue
Am J Psychiatry 2004 161: A48. [Full Text] [PDF]

This article has been cited by other articles:

				S. L. Eastwood, L. Lyon, L. George, A. Andrieux, D. Job, and P. J. Harrison Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice J Psychopharmacol, August 1, 2007; 21(6): 635 - 644. [Abstract] [PDF]

				B. M. Ances, R. Vitaliani, R. A. Taylor, D. S. Liebeskind, A. Voloschin, D. J. Houghton, S. L. Galetta, M. Dichter, A. Alavi, M. R. Rosenfeld, et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates Brain, August 1, 2005; 128(8): 1764 - 1777. [Abstract] [Full Text] [PDF]

				A. J. DWORK, G. ROSOKLIJA, and L. B. JONES Reduced Spinophilin in Schizophrenia Am J Psychiatry, July 1, 2005; 162(7): 1389 - 1389. [Full Text] [PDF]

				L. M. Talamini, M. Meeter, B. Elvevag, J. M. J. Murre, and T. E. Goldberg Reduced Parahippocampal Connectivity Produces Schizophrenia-like Memory Deficits in Simulated Neural Circuits With Reduced Parahippocampal Connectivity Arch Gen Psychiatry, May 1, 2005; 62(5): 485 - 493. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us